On December 3, 2021, Phreesia (NYSE:PHR) entered into an agreement to acquire Insignia Health, LLC.

The Healthcare M&A practice of Duff & Phelps, A Kroll Business, served as exclusive financial advisor to Insignia Health in connection with the transaction.

About Insignia Health
Insignia Health is the leading scientifically anchored health activation SaaS platform that provides healthcare payors, providers and pharmaceutical companies with predictive risk insights which are missed by claims and utilization data. The Company’s proprietary Patient Activation Measure® (PAM) platform quantifies a patient’s self-management ability and then guides more person-centered and effective support that improves healthcare outcomes and lowers costs. PAM is used in over 32 countries and nearly three dozen languages and has been proven to be effective across populations, demographics and cultures. The PAM platform has been adopted by large U.S. and international government and commercial payors, health systems and life science firms, including CMS, England’s NHS, regional health plans in more than 20 states and health systems in more than 35 states. Faegre Drinker Biddle & Reath LLP served as legal counsel to Insignia Health.

About Phreesia
Phreesia (NYSE:PHR) offers healthcare provider organizations a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. Its solutions cover several areas including Allergy, Cardiology, Dermatology, Family Medicine, Neurology and Oncology among others. The Phreesia Platform offers the following solutions to its clients: registration solutions, patient activation solutions, revenue cycle solutions, clinical support solutions, appointment solutions and life sciences solutions. Goodwin Procter LLP served as legal counsel to Phreesia.